Floor & Decor Holdings (FND) shares have retreated over 7% this week, sparking debate among investors. While the home improvement retailer posts solid revenue of $4.66 billion, its premium valuation and aggressive expansion plans face a cooling housing market test.
Comcast announces a major restructuring of its connectivity division, appointing a new CEO, as it navigates a $240 million patent loss and gears up for a pivotal sports streaming season with the Olympics and Super Bowl on the horizon.
Shares of Philip Morris International have significantly outperformed the market over the past year, buoyed by its strategic shift towards reduced-risk products. While analysts remain broadly positive, recent downgrades signal growing caution about the pace of transformation and valuation.
Shoppers are bracing for another wave of price increases as new import taxes take effect, targeting a range of everyday items from spirits to seafood. Experts warn the hikes will squeeze household budgets and force tough choices at the supermarket.
Despite a post-earnings sell-off, Netflix's burgeoning advertising business is laying the groundwork for sustained profit growth, presenting a potential value entry for long-term investors.
Goldman Sachs raises Sweetgreen's price target to $5.60, citing policy tailwinds for consumer spending, even as it maintains a Sell rating. The salad chain's expansion and strong revenue growth continue to draw investor attention.
Despite a modest price target reduction, Morgan Stanley reaffirms its Overweight rating on Wingstop, citing the chicken wing chain's robust unit expansion and system-wide sales momentum as key drivers for its 2026 outlook.
BMO Capital maintains its Outperform rating on Primo Brands Corporation (PRMB) despite lowering its price target, citing strong premium brand growth and a long-term recovery path for its direct-to-consumer segment.
Citigroup initiates coverage of Dutch Bros Inc. with a Buy rating and an $82 price target, citing the drive-through coffee chain's successful national scaling and multiple drivers for sustained same-store sales growth over the coming years.
A sustained plunge in the U.S. dollar's value, driven by soaring debt and geopolitical estrangement, threatens higher consumer costs, rising borrowing rates, and a sharp decline in foreign investment, economists warn.
Russian pipeline gas exports to Europe via TurkStream increased in January, even as the EU finalizes a sweeping ban and Moscow's overall sales hit a multi-decade low, underscoring the continent's complex and uneven energy transition.
Southwest Airlines' stock just logged its biggest daily gain since 1978, fueled by a decisive break from its past. As bag fees, assigned seating, and new revenue streams take hold, the carrier's bold transformation is winning over Wall Street and setting the stage for a projected profit surge.
Lake Street Capital maintains a Buy rating on The ONE Group Hospitality (STKS) despite lowering its price target, citing a solid finish in a tough market and a clear growth runway through 2026.
JPMorgan raises its price target for Celsius Holdings (CELH) to $77, citing upside potential from its deepening PepsiCo partnership and the expanding distribution of its Alani Nu brand ahead of Q4 earnings.
Analyst Piper Sandler has lowered its price target on Black Diamond Therapeutics (BDTX) while maintaining an Overweight rating, following a broad review of its biotech coverage. The adjustment comes even as the company recently reported encouraging Phase 2 data for its lead oncology drug candidate.
A federal appeals court has dismissed a Justice Department misconduct complaint against U.S. District Judge James Boasberg, ruling the government failed to substantiate its allegations regarding the judge's public comments.
New data ranks the greater Hartford area as the fourth most competitive housing market in the U.S., with a critically low 3.3-month supply driving projections of a 17.1% surge in median home prices this year.
As Bob Iger prepares to step down, he highlights a 'healthy competition' between Disney's resurgent parks and its entertainment division to become the company's primary profit driver, with the board close to naming his successor.
Wells Fargo boosts its price target for Taysha Gene Therapies (TSHA), citing strong progress in its pivotal Rett syndrome gene therapy program. The company has dosed the first patient in a key trial phase and received FDA alignment on its regulatory pathway.
Following a price target adjustment by Leerink Partners, Kura Oncology (KURA) is drawing investor focus to its 2026 clinical milestones and commercial strategy for its newly launched AML drug, ziftomenib.
